Heat shock 10 kDa protein 1 (Hsp10), also known as chaperonin 10 (cpn10) or early-pregnancy factor (EPF), is a protein that in humans is encoded by the HSPE1 gene. The homolog in E. coli is GroES that is a chaperonin which usually works in conjunction with GroEL.[5]
Quick Facts HSPE1, Available structures ...
Close
Quick Facts Cpn10, Identifiers ...
Close
GroES exists as a ring-shaped oligomer of between six and eight identical subunits, while the 60 kDa chaperonin (cpn60, or groEL in bacteria) forms a structure comprising 2 stacked rings, each ring containing 7 identical subunits.[6] These ring structures assemble by self-stimulation in the presence of Mg2+-ATP. The central cavity of the cylindrical cpn60 tetradecamer provides an isolated environment for protein folding whilst cpn-10 binds to cpn-60 and synchronizes the release of the folded protein in an Mg2+-ATP dependent manner.[7] The binding of cpn10 to cpn60 inhibits the weak ATPase activity of cpn60.
Escherichia coli GroES has also been shown to bind ATP cooperatively, and with an affinity comparable to that of GroEL.[8] Each GroEL subunit contains three structurally distinct domains: an apical, an intermediate and an equatorial domain. The apical domain contains the binding sites for both GroES and the unfolded protein substrate. The equatorial domain contains the ATP-binding site and most of the oligomeric contacts. The intermediate domain links the apical and equatorial domains and transfers allosteric information between them. The GroEL oligomer is a tetradecamer, cylindrically shaped, that is organised in two heptameric rings stacked back to back. Each GroEL ring contains a central cavity, known as the `Anfinsen cage', that provides an isolated environment for protein folding. The identical 10 kDa subunits of GroES form a dome-like heptameric oligomer in solution. ATP binding to GroES may be important in charging the seven subunits of the interacting GroEL ring with ATP, to facilitate cooperative ATP binding and hydrolysis for substrate protein release.
GroES has been shown to interact with GroEL.[9][10]
Early pregnancy factor is tested for rosette inhibition assay. EPF is present in the maternal serum (blood plasma) shortly after fertilization; EPF is also present in cervical mucus
[11] and in amniotic fluid.[12]
EPF may be detected in sheep within 72 hours of mating,[13] in mice within 24 hours of mating,[14] and in samples from media surrounding human embryos fertilized in vitro within 48 hours of fertilization[15] (although another study failed to duplicate this finding for in vitro embryos).[16] EPF has been detected as soon as within six hours of mating.[17]
Because the rosette inhibition assay for EPF is indirect, substances that have similar effects may confound the test. Pig semen, like EPF, has been shown to inhibit rosette formation – the rosette inhibition test was positive for one day in sows mated with a vasectomized boar, but not in sows similarly stimulated without semen exposure.[18] A number of studies in the years after the discovery of EPF were unable to reproduce the consistent detection of EPF in post-conception females, and the validity of the discovery experiments was questioned.[19] However, progress in characterization of EPF has been made and its existence is well-accepted in the scientific community.[20][21]
Early embryos are not believed to directly produce EPF. Rather, embryos are believed to produce some other chemical that induces the maternal system to create EPF.[22][23][24][25][26] After implantation, EPF may be produced by the conceptus directly.[16]
EPF is an immunosuppressant. Along with other substances associated with early embryos, EPF is believed to play a role in preventing the immune system of the pregnant female from attacking the embryo.[17][27] Injecting anti-EPF antibodies into mice after mating significantly [quantify] reduced the number of successful pregnancies and number of pups;[28][29] no effect on growth was seen when mice embryos were cultured in media containing anti-EPF antibodies.[30] While some actions of EPF are the same in all mammals (namely rosette inhibition), other immunosuppressant mechanism vary between species.[31]
In mice, EPF levels are high in early pregnancy, but on day 15 decline to levels found in non-pregnant mice.[32] In humans, EPF levels are high for about the first twenty weeks, then decline, becoming undetectable within eight weeks of delivery.[33][34]
Pregnancy testing
It has been suggested that EPF could be used as a marker for a very early pregnancy test, and as a way to monitor the viability of ongoing pregnancies in livestock.[13] Interest in EPF for this purpose has continued,[35] although current test methods have not proved sufficiently accurate for the requirements of livestock management.[36][37][38][39]
In humans, modern pregnancy tests detect human chorionic gonadotropin (hCG). hCG is not present until after implantation, which occurs six to twelve days after fertilization.[40] In contrast, EPF is present within hours of fertilization. While several other pre-implantation signals have been identified, EPF is believed to be the earliest possible marker of pregnancy.[14][41] The accuracy of EPF as a pregnancy test in humans has been found to be high by several studies.[42][43][44][45]
Birth control research
EPF may also be used to determine whether pregnancy prevention mechanism of birth control methods act before or after fertilization. A 1982 study evaluating EPF levels in women with IUDs concluded that post-fertilization mechanisms contribute significantly[quantify] to the effectiveness of these devices.[46] However, more recent evidence, such as tubal flushing studies indicates that IUDs work by inhibiting fertilization, acting earlier in the reproductive process than previously thought.[47]
For groups that define pregnancy as beginning with fertilization, birth control methods that have postfertilization mechanisms are regarded as abortifacient. There is currently contention over whether hormonal contraception methods have post-fertilization methods, specifically the most popular hormonal method: the combined oral contraceptive pill (COCP). The group Pharmacists for Life has called for a large-scale clinical trial to evaluate EPF in women taking COCPs; this would be the most conclusive evidence available to determine whether COCPs have postfertilization mechanisms.[48]
Infertility and early pregnancy loss
EPF is useful when investigating embryo loss prior to implantation. One study in healthy human women seeking pregnancy detected fourteen pregnancies with EPF. Of these, six were lost within ten days of ovulation (43% rate of early conceptus loss).[49]
Use of EPF has been proposed to distinguish infertility caused by failure to conceive versus infertility caused by failure to implant.[50] EPF has also been proposed as a marker of viable pregnancy, more useful in distinguishing ectopic or other nonviable pregnancies than other chemical markers such as hCG and progesterone.[51][52][53][54]
As a tumour marker
Although almost exclusively associated with pregnancy, EPF-like activity has also been detected in tumors of germ cell origin[55][56] and in other types of tumors.[57] Its utility as a tumour marker, to evaluate the success of surgical treatment, has been suggested.[58]
Lee KH, Kim HS, Jeong HS, Lee YS (October 2002). "Chaperonin GroESL mediates the protein folding of human liver mitochondrial aldehyde dehydrogenase in Escherichia coli". Biochem. Biophys. Res. Commun. 298 (2): 216–24. doi:10.1016/S0006-291X(02)02423-3. PMID 12387818. Koch E, Ellendorff F (May 1985). "Detection of activity similar to that of early pregnancy factor after mating sows with a vasectomized boar". Journal of Reproduction and Fertility. 74 (1): 39–46. doi:10.1530/jrf.0.0740039. PMID 4020773. Chard T, Grudzinskas JG (1987). "Early pregnancy factor". Biological Research in Pregnancy and Perinatology. 8 (2 2D Half): 53–6. PMID 3322417. Di Trapani G, Orosco C, Perkins A, Clarke F (Mar 1991). "Isolation from human placental extracts of a preparation possessing 'early pregnancy factor' activity and identification of the polypeptide components". Human Reproduction. 6 (3): 450–7. doi:10.1093/oxfordjournals.humrep.a137357. PMID 1955557. Cavanagh AC (Jan 1996). "Identification of early pregnancy factor as chaperonin 10: implications for understanding its role". Reviews of Reproduction. 1 (1): 28–32. doi:10.1530/ror.0.0010028. PMID 9414435. Roberts TK, Adamson LM, Smart YC, Stanger JD, Murdoch RN (May 1987). "An evaluation of peripheral blood platelet enumeration as a monitor of fertilization and early pregnancy". Fertility and Sterility. 47 (5): 848–54. doi:10.1016/S0015-0282(16)59177-8. PMID 3569561. Sueoka K, Dharmarajan AM, Miyazaki T, Atlas SJ, Wallach EE (Dec 1988). "Platelet activating factor-induced early pregnancy factor activity from the perfused rabbit ovary and oviduct". American Journal of Obstetrics and Gynecology. 159 (6): 1580–4. doi:10.1016/0002-9378(88)90598-4. PMID 3207134. Bose R, Cheng H, Sabbadini E, McCoshen J, MaHadevan MM, Fleetham J (Apr 1989). "Purified human early pregnancy factor from preimplantation embryo possesses immunosuppresive properties". American Journal of Obstetrics and Gynecology. 160 (4): 954–60. doi:10.1016/0002-9378(89)90316-5. PMID 2712125. Igarashi S (Feb 1987). "[Significance of early pregnancy factor (EPF) on reproductive immunology]". Nihon Sanka Fujinka Gakkai Zasshi. 39 (2): 189–94. PMID 2950188. Greco CR, Vivas AB, Bosch RA (1992). "[Evaluation of the method for early pregnancy factor detection (EPF) in swine. Significance in early pregnancy diagnosis]". Acta Physiologica, Pharmacologica et Therapeutica Latinoamericana. 42 (1): 43–50. PMID 1294272. Sasser RG, Ruder CA (1987). "Detection of early pregnancy in domestic ruminants". Journal of Reproduction and Fertility. Supplement. 34: 261–71. PMID 3305923. Gandy B, Tucker W, Ryan P, Williams A, Tucker A, Moore A, Godfrey R, Willard S (Sep 2001). "Evaluation of the early conception factor (ECF) test for the detection of nonpregnancy in dairy cattle". Theriogenology. 56 (4): 637–47. doi:10.1016/S0093-691X(01)00595-7. PMID 11572444. Straube W (1989). "[Early embryonal signals]". Zentralblatt für Gynäkologie. 111 (10): 629–33. PMID 2665388. Bessho T, Taira S, Ikuma K, Shigeta M, Koyama K, Isojima S (Mar 1984). "[Detection of early pregnancy factor in the sera of conceived women before nidation]". Nihon Sanka Fujinka Gakkai Zasshi. 36 (3): 391–6. PMID 6715922. Straube W, Tiemann U, Loh M, Schütz M (1989). "Detection of early pregnancy factor (EPF) in pregnant and nonpregnant subjects with the rosette inhibition test". Archives of Gynecology and Obstetrics. 246 (3): 181–7. doi:10.1007/BF00934079. PMID 2619332. S2CID 20531983. Smart YC, Fraser IS, Roberts TK, Clancy RL, Cripps AW (Sep 1982). "Fertilization and early pregnancy loss in healthy women attempting conception". Clinical Reproduction and Fertility. 1 (3): 177–84. PMID 6196101. Mesrogli M, Maas DH, Schneider J (1988). "[Early abortion rate in sterility patients: early pregnancy factor as a parameter]". Zentralblatt für Gynäkologie. 110 (9): 555–61. PMID 3407357. Straube W, Loh M, Leipe S (Dec 1988). "[Significance of the detection of early pregnancy factor for monitoring normal and disordered early pregnancy]". Geburtshilfe und Frauenheilkunde. 48 (12): 854–8. doi:10.1055/s-2008-1026640. PMID 2466731. S2CID 260158786. Gerhard I, Katzer E, Runnebaum B (1991). "The early pregnancy factor (EPF) in pregnancies of women with habitual abortions". Early Human Development. 26 (2): 83–92. doi:10.1016/0378-3782(91)90012-R. PMID 1720719. Shahani SK, Moniz CL, Bordekar AD, Gupta SM, Naik K (1994). "Early pregnancy factor as a marker for assessing embryonic viability in threatened and missed abortions". Gynecologic and Obstetric Investigation. 37 (2): 73–6. doi:10.1159/000292528. PMID 8150373. Mehta AR, Shahani SK (Jul 1987). "Detection of early pregnancy factor-like activity in women with gestational trophoblastic tumors". American Journal of Reproductive Immunology and Microbiology. 14 (3): 67–9. doi:10.1111/j.1600-0897.1987.tb00122.x. PMID 2823620. Bojahr B, Straube W, Reddemann H (1993). "[Case observations on the significance of early pregnancy factor as a tumor marker]". Zentralblatt für Gynäkologie. 115 (3): 125–8. PMID 7682025.
- Czarnecka AM, Campanella C, Zummo G, Cappello F (2006). "Heat shock protein 10 and signal transduction: a "capsula eburnea" of carcinogenesis?". Cell Stress & Chaperones. 11 (4): 287–94. doi:10.1379/CSC-200.1 (inactive 1 November 2024). PMC 1713189. PMID 17278877.
{{cite journal}}: CS1 maint: DOI inactive as of November 2024 (link)
- Legname G, Fossati G, Gromo G, Monzini N, Marcucci F, Modena D (1995). "Expression in Escherichia coli, purification and functional activity of recombinant human chaperonin 10". FEBS Lett. 361 (2–3): 211–4. Bibcode:1995FEBSL.361..211L. doi:10.1016/0014-5793(95)00184-B. PMID 7698325. S2CID 22185852.
- Cavanagh AC, Morton H (1994). "The purification of early-pregnancy factor to homogeneity from human platelets and identification as chaperonin 10". Eur. J. Biochem. 222 (2): 551–60. doi:10.1111/j.1432-1033.1994.tb18897.x. PMID 7912672.
- Monzini N, Legname G, Marcucci F, Gromo G, Modena D (1994). "Identification and cloning of human chaperonin 10 homologue". Biochim. Biophys. Acta. 1218 (3): 478–80. doi:10.1016/0167-4781(94)90211-9. PMID 7914093.
- Chen JJ, McNealy DJ, Dalal S, Androphy EJ (1994). "Isolation, sequence analysis and characterization of a cDNA encoding human chaperonin 10". Biochim. Biophys. Acta. 1219 (1): 189–90. doi:10.1016/0167-4781(94)90268-2. PMID 7916212.
- Samali A, Cai J, Zhivotovsky B, Jones DP, Orrenius S (1999). "Presence of a pre-apoptotic complex of pro-caspase-3, Hsp60 and Hsp10 in the mitochondrial fraction of jurkat cells". EMBO J. 18 (8): 2040–8. doi:10.1093/emboj/18.8.2040. PMC 1171288. PMID 10205158.
- Summers KM, Fletcher BH, Macaranas DD, Somodevilla-Torres MJ, Murphy RM, Osborne MJ, Spurr NK, Cassady AI, Cavanagh AC (1998). "Mapping and characterization of the eukaryotic early pregnancy factor/chaperonin 10 gene family". Somat. Cell Mol. Genet. 24 (6): 315–26. doi:10.1023/A:1024488422990. PMID 10763410. S2CID 39860709.
- Richardson A, Schwager F, Landry SJ, Georgopoulos C (2001). "The importance of a mobile loop in regulating chaperonin/ co-chaperonin interaction: humans versus Escherichia coli". J. Biol. Chem. 276 (7): 4981–7. doi:10.1074/jbc.M008628200. PMID 11050098.
- Fletcher BH, Cassady AI, Summers KM, Cavanagh AC (2001). "The murine chaperonin 10 gene family contains an intronless, putative gene for early pregnancy factor, Cpn10-rs1". Mamm. Genome. 12 (2): 133–40. doi:10.1007/s003350010250. PMID 11210183. S2CID 21105180.
- Parissi V, Calmels C, De Soultrait VR, Caumont A, Fournier M, Chaignepain S, Litvak S (2001). "Functional interactions of human immunodeficiency virus type 1 integrase with human and yeast HSP60". J. Virol. 75 (23): 11344–53. doi:10.1128/JVI.75.23.11344-11353.2001. PMC 114720. PMID 11689615.
- Hansen JJ, Dürr A, Cournu-Rebeix I, Georgopoulos C, Ang D, Nielsen MN, Davoine CS, Brice A, Fontaine B, Gregersen N, Bross P (2002). "Hereditary spastic paraplegia SPG13 is associated with a mutation in the gene encoding the mitochondrial chaperonin Hsp60". Am. J. Hum. Genet. 70 (5): 1328–32. doi:10.1086/339935. PMC 447607. PMID 11898127.
- Guidry JJ, Wittung-Stafshede P (2002). "Low stability for monomeric human chaperonin protein 10: interprotein interactions contribute majority of oligomer stability". Arch. Biochem. Biophys. 405 (2): 280–2. doi:10.1016/S0003-9861(02)00406-X. PMID 12220543.
- Lee KH, Kim HS, Jeong HS, Lee YS (2002). "Chaperonin GroESL mediates the protein folding of human liver mitochondrial aldehyde dehydrogenase in Escherichia coli". Biochem. Biophys. Res. Commun. 298 (2): 216–24. doi:10.1016/S0006-291X(02)02423-3. PMID 12387818.
- Hansen JJ, Bross P, Westergaard M, Nielsen MN, Eiberg H, Børglum AD, Mogensen J, Kristiansen K, Bolund L, Gregersen N (2003). "Genomic structure of the human mitochondrial chaperonin genes: HSP60 and HSP10 are localised head to head on chromosome 2 separated by a bidirectional promoter". Hum. Genet. 112 (1): 71–7. doi:10.1007/s00439-002-0837-9. PMID 12483302. S2CID 25856774.
- Mansell JP, Yarram SJ, Brown NL, Sandy JR (2002). "Type I collagen synthesis by human osteoblasts in response to placental lactogen and chaperonin 10, a homolog of early-pregnancy factor". In Vitro Cell. Dev. Biol. Anim. 38 (9): 518–22. doi:10.1290/1071-2690(2002)038<0518:TICSBH>2.0.CO;2. PMID 12703979. S2CID 24606162.
- Cappello F, Bellafiore M, David S, Anzalone R, Zummo G (2003). "Ten kilodalton heat shock protein (HSP10) is overexpressed during carcinogenesis of large bowel and uterine exocervix" (PDF). Cancer Lett. 196 (1): 35–41. doi:10.1016/S0304-3835(03)00212-X. hdl:10447/191095. PMID 12860287.
- Shan YX, Liu TJ, Su HF, Samsamshariat A, Mestril R, Wang PH (2003). "Hsp10 and Hsp60 modulate Bcl-2 family and mitochondria apoptosis signaling induced by doxorubicin in cardiac muscle cells". J. Mol. Cell. Cardiol. 35 (9): 1135–43. doi:10.1016/S0022-2828(03)00229-3. PMID 12967636.
- Shan YX, Yang TL, Mestril R, Wang PH (2003). "Hsp10 and Hsp60 suppress ubiquitination of insulin-like growth factor-1 receptor and augment insulin-like growth factor-1 receptor signaling in cardiac muscle: implications on decreased myocardial protection in diabetic cardiomyopathy". J. Biol. Chem. 278 (46): 45492–8. doi:10.1074/jbc.M304498200. PMID 12970367.
- Guidry JJ, Shewmaker F, Maskos K, Landry S, Wittung-Stafshede P (2003). "Probing the interface in a human co-chaperonin heptamer: residues disrupting oligomeric unfolded state identified". BMC Biochem. 4: 14. doi:10.1186/1471-2091-4-14. PMC 270013. PMID 14525625.
